Patient-specific dosing of IIb/IIIa antagonists during acute coronary syndromes: rationale and design of the PARAGON B study. The PARAGON B International Steering Committee.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples